Global Vaccine Adjuvants Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Vaccine Adjuvants market size is predicted to grow from US$ 719 million in 2025 to US$ 1208 million in 2031; it is expected to grow at a CAGR of 9.0% from 2025 to 2031.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The vaccine adjuvants market is driven by the increasing need for more effective and long-lasting vaccines. Adjuvants are substances added to vaccines to enhance the body’s immune response, making vaccines more effective, especially in cases where the antigen alone may not provide sufficient protection. The growing prevalence of infectious diseases and the rising demand for vaccines to address new and emerging pathogens, such as COVID-19 variants, are fueling the development and adoption of advanced adjuvants. Additionally, ongoing research and development in immunology and biotechnology are leading to the creation of novel adjuvants that improve vaccine efficacy and safety.
One of the main challenges in the vaccine adjuvants market is the complexity and cost associated with developing and producing new adjuvants. The process requires significant investment in research and development, as well as rigorous testing to ensure safety and effectiveness. Additionally, there are regulatory hurdles that must be overcome, as new adjuvants need to meet stringent guidelines before they can be approved for use. Public concerns about vaccine safety and the potential for adverse reactions to adjuvants also pose challenges, as any negative perceptions can impact vaccine acceptance and adoption.
LP Information, Inc. (LPI) ' newest research report, the “Vaccine Adjuvants Industry Forecast” looks at past sales and reviews total world Vaccine Adjuvants sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine Adjuvants sales for 2025 through 2031. With Vaccine Adjuvants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Adjuvants industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Adjuvants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine Adjuvants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine Adjuvants market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Adjuvants and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Adjuvants.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Adjuvants market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Vaccine Adjuvants market?
What factors are driving Vaccine Adjuvants market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccine Adjuvants market opportunities vary by end market size?
How does Vaccine Adjuvants break out by Type, by Application?
The global Vaccine Adjuvants market size is predicted to grow from US$ 719 million in 2025 to US$ 1208 million in 2031; it is expected to grow at a CAGR of 9.0% from 2025 to 2031.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The vaccine adjuvants market is driven by the increasing need for more effective and long-lasting vaccines. Adjuvants are substances added to vaccines to enhance the body’s immune response, making vaccines more effective, especially in cases where the antigen alone may not provide sufficient protection. The growing prevalence of infectious diseases and the rising demand for vaccines to address new and emerging pathogens, such as COVID-19 variants, are fueling the development and adoption of advanced adjuvants. Additionally, ongoing research and development in immunology and biotechnology are leading to the creation of novel adjuvants that improve vaccine efficacy and safety.
One of the main challenges in the vaccine adjuvants market is the complexity and cost associated with developing and producing new adjuvants. The process requires significant investment in research and development, as well as rigorous testing to ensure safety and effectiveness. Additionally, there are regulatory hurdles that must be overcome, as new adjuvants need to meet stringent guidelines before they can be approved for use. Public concerns about vaccine safety and the potential for adverse reactions to adjuvants also pose challenges, as any negative perceptions can impact vaccine acceptance and adoption.
LP Information, Inc. (LPI) ' newest research report, the “Vaccine Adjuvants Industry Forecast” looks at past sales and reviews total world Vaccine Adjuvants sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine Adjuvants sales for 2025 through 2031. With Vaccine Adjuvants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Adjuvants industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Adjuvants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine Adjuvants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine Adjuvants market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Adjuvants and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Adjuvants.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Adjuvants market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Emulsion Adjuvants
- Mineral Adjuvants
- Others
- Human Vaccine
- Veterinary Vaccine
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- CSL Limited
- Croda
- SEPPIC
- Sanofi
- Zhifei Biological
- Escon
- Huanuotai Biological
- Rico Bio
- SDA BIO
- SPI Pharma
- Phibro Animal Health
- Vertellus
What is the 10-year outlook for the global Vaccine Adjuvants market?
What factors are driving Vaccine Adjuvants market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccine Adjuvants market opportunities vary by end market size?
How does Vaccine Adjuvants break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Adjuvants Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Vaccine Adjuvants by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Vaccine Adjuvants by Country/Region, 2020, 2024 & 2031
2.2 Vaccine Adjuvants Segment by Type
2.2.1 Emulsion Adjuvants
2.2.2 Mineral Adjuvants
2.2.3 Others
2.3 Vaccine Adjuvants Sales by Type
2.3.1 Global Vaccine Adjuvants Sales Market Share by Type (2020-2025)
2.3.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2020-2025)
2.3.3 Global Vaccine Adjuvants Sale Price by Type (2020-2025)
2.4 Vaccine Adjuvants Segment by Application
2.4.1 Human Vaccine
2.4.2 Veterinary Vaccine
2.5 Vaccine Adjuvants Sales by Application
2.5.1 Global Vaccine Adjuvants Sale Market Share by Application (2020-2025)
2.5.2 Global Vaccine Adjuvants Revenue and Market Share by Application (2020-2025)
2.5.3 Global Vaccine Adjuvants Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Vaccine Adjuvants Breakdown Data by Company
3.1.1 Global Vaccine Adjuvants Annual Sales by Company (2020-2025)
3.1.2 Global Vaccine Adjuvants Sales Market Share by Company (2020-2025)
3.2 Global Vaccine Adjuvants Annual Revenue by Company (2020-2025)
3.2.1 Global Vaccine Adjuvants Revenue by Company (2020-2025)
3.2.2 Global Vaccine Adjuvants Revenue Market Share by Company (2020-2025)
3.3 Global Vaccine Adjuvants Sale Price by Company
3.4 Key Manufacturers Vaccine Adjuvants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine Adjuvants Product Location Distribution
3.4.2 Players Vaccine Adjuvants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VACCINE ADJUVANTS BY GEOGRAPHIC REGION
4.1 World Historic Vaccine Adjuvants Market Size by Geographic Region (2020-2025)
4.1.1 Global Vaccine Adjuvants Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Vaccine Adjuvants Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Vaccine Adjuvants Market Size by Country/Region (2020-2025)
4.2.1 Global Vaccine Adjuvants Annual Sales by Country/Region (2020-2025)
4.2.2 Global Vaccine Adjuvants Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccine Adjuvants Sales Growth
4.4 APAC Vaccine Adjuvants Sales Growth
4.5 Europe Vaccine Adjuvants Sales Growth
4.6 Middle East & Africa Vaccine Adjuvants Sales Growth
5 AMERICAS
5.1 Americas Vaccine Adjuvants Sales by Country
5.1.1 Americas Vaccine Adjuvants Sales by Country (2020-2025)
5.1.2 Americas Vaccine Adjuvants Revenue by Country (2020-2025)
5.2 Americas Vaccine Adjuvants Sales by Type (2020-2025)
5.3 Americas Vaccine Adjuvants Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Adjuvants Sales by Region
6.1.1 APAC Vaccine Adjuvants Sales by Region (2020-2025)
6.1.2 APAC Vaccine Adjuvants Revenue by Region (2020-2025)
6.2 APAC Vaccine Adjuvants Sales by Type (2020-2025)
6.3 APAC Vaccine Adjuvants Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine Adjuvants by Country
7.1.1 Europe Vaccine Adjuvants Sales by Country (2020-2025)
7.1.2 Europe Vaccine Adjuvants Revenue by Country (2020-2025)
7.2 Europe Vaccine Adjuvants Sales by Type (2020-2025)
7.3 Europe Vaccine Adjuvants Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine Adjuvants by Country
8.1.1 Middle East & Africa Vaccine Adjuvants Sales by Country (2020-2025)
8.1.2 Middle East & Africa Vaccine Adjuvants Revenue by Country (2020-2025)
8.2 Middle East & Africa Vaccine Adjuvants Sales by Type (2020-2025)
8.3 Middle East & Africa Vaccine Adjuvants Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine Adjuvants
10.3 Manufacturing Process Analysis of Vaccine Adjuvants
10.4 Industry Chain Structure of Vaccine Adjuvants
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine Adjuvants Distributors
11.3 Vaccine Adjuvants Customer
12 WORLD FORECAST REVIEW FOR VACCINE ADJUVANTS BY GEOGRAPHIC REGION
12.1 Global Vaccine Adjuvants Market Size Forecast by Region
12.1.1 Global Vaccine Adjuvants Forecast by Region (2026-2031)
12.1.2 Global Vaccine Adjuvants Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Vaccine Adjuvants Forecast by Type (2026-2031)
12.7 Global Vaccine Adjuvants Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Vaccine Adjuvants Product Portfolios and Specifications
13.1.3 GSK Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 CSL Limited
13.2.1 CSL Limited Company Information
13.2.2 CSL Limited Vaccine Adjuvants Product Portfolios and Specifications
13.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Limited Main Business Overview
13.2.5 CSL Limited Latest Developments
13.3 Croda
13.3.1 Croda Company Information
13.3.2 Croda Vaccine Adjuvants Product Portfolios and Specifications
13.3.3 Croda Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Croda Main Business Overview
13.3.5 Croda Latest Developments
13.4 SEPPIC
13.4.1 SEPPIC Company Information
13.4.2 SEPPIC Vaccine Adjuvants Product Portfolios and Specifications
13.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 SEPPIC Main Business Overview
13.4.5 SEPPIC Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Vaccine Adjuvants Product Portfolios and Specifications
13.5.3 Sanofi Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Zhifei Biological
13.6.1 Zhifei Biological Company Information
13.6.2 Zhifei Biological Vaccine Adjuvants Product Portfolios and Specifications
13.6.3 Zhifei Biological Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Zhifei Biological Main Business Overview
13.6.5 Zhifei Biological Latest Developments
13.7 Escon
13.7.1 Escon Company Information
13.7.2 Escon Vaccine Adjuvants Product Portfolios and Specifications
13.7.3 Escon Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Escon Main Business Overview
13.7.5 Escon Latest Developments
13.8 Huanuotai Biological
13.8.1 Huanuotai Biological Company Information
13.8.2 Huanuotai Biological Vaccine Adjuvants Product Portfolios and Specifications
13.8.3 Huanuotai Biological Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Huanuotai Biological Main Business Overview
13.8.5 Huanuotai Biological Latest Developments
13.9 Rico Bio
13.9.1 Rico Bio Company Information
13.9.2 Rico Bio Vaccine Adjuvants Product Portfolios and Specifications
13.9.3 Rico Bio Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Rico Bio Main Business Overview
13.9.5 Rico Bio Latest Developments
13.10 SDA BIO
13.10.1 SDA BIO Company Information
13.10.2 SDA BIO Vaccine Adjuvants Product Portfolios and Specifications
13.10.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 SDA BIO Main Business Overview
13.10.5 SDA BIO Latest Developments
13.11 SPI Pharma
13.11.1 SPI Pharma Company Information
13.11.2 SPI Pharma Vaccine Adjuvants Product Portfolios and Specifications
13.11.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 SPI Pharma Main Business Overview
13.11.5 SPI Pharma Latest Developments
13.12 Phibro Animal Health
13.12.1 Phibro Animal Health Company Information
13.12.2 Phibro Animal Health Vaccine Adjuvants Product Portfolios and Specifications
13.12.3 Phibro Animal Health Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Phibro Animal Health Main Business Overview
13.12.5 Phibro Animal Health Latest Developments
13.13 Vertellus
13.13.1 Vertellus Company Information
13.13.2 Vertellus Vaccine Adjuvants Product Portfolios and Specifications
13.13.3 Vertellus Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Vertellus Main Business Overview
13.13.5 Vertellus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Adjuvants Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Vaccine Adjuvants by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Vaccine Adjuvants by Country/Region, 2020, 2024 & 2031
2.2 Vaccine Adjuvants Segment by Type
2.2.1 Emulsion Adjuvants
2.2.2 Mineral Adjuvants
2.2.3 Others
2.3 Vaccine Adjuvants Sales by Type
2.3.1 Global Vaccine Adjuvants Sales Market Share by Type (2020-2025)
2.3.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2020-2025)
2.3.3 Global Vaccine Adjuvants Sale Price by Type (2020-2025)
2.4 Vaccine Adjuvants Segment by Application
2.4.1 Human Vaccine
2.4.2 Veterinary Vaccine
2.5 Vaccine Adjuvants Sales by Application
2.5.1 Global Vaccine Adjuvants Sale Market Share by Application (2020-2025)
2.5.2 Global Vaccine Adjuvants Revenue and Market Share by Application (2020-2025)
2.5.3 Global Vaccine Adjuvants Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Vaccine Adjuvants Breakdown Data by Company
3.1.1 Global Vaccine Adjuvants Annual Sales by Company (2020-2025)
3.1.2 Global Vaccine Adjuvants Sales Market Share by Company (2020-2025)
3.2 Global Vaccine Adjuvants Annual Revenue by Company (2020-2025)
3.2.1 Global Vaccine Adjuvants Revenue by Company (2020-2025)
3.2.2 Global Vaccine Adjuvants Revenue Market Share by Company (2020-2025)
3.3 Global Vaccine Adjuvants Sale Price by Company
3.4 Key Manufacturers Vaccine Adjuvants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine Adjuvants Product Location Distribution
3.4.2 Players Vaccine Adjuvants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VACCINE ADJUVANTS BY GEOGRAPHIC REGION
4.1 World Historic Vaccine Adjuvants Market Size by Geographic Region (2020-2025)
4.1.1 Global Vaccine Adjuvants Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Vaccine Adjuvants Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Vaccine Adjuvants Market Size by Country/Region (2020-2025)
4.2.1 Global Vaccine Adjuvants Annual Sales by Country/Region (2020-2025)
4.2.2 Global Vaccine Adjuvants Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccine Adjuvants Sales Growth
4.4 APAC Vaccine Adjuvants Sales Growth
4.5 Europe Vaccine Adjuvants Sales Growth
4.6 Middle East & Africa Vaccine Adjuvants Sales Growth
5 AMERICAS
5.1 Americas Vaccine Adjuvants Sales by Country
5.1.1 Americas Vaccine Adjuvants Sales by Country (2020-2025)
5.1.2 Americas Vaccine Adjuvants Revenue by Country (2020-2025)
5.2 Americas Vaccine Adjuvants Sales by Type (2020-2025)
5.3 Americas Vaccine Adjuvants Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Adjuvants Sales by Region
6.1.1 APAC Vaccine Adjuvants Sales by Region (2020-2025)
6.1.2 APAC Vaccine Adjuvants Revenue by Region (2020-2025)
6.2 APAC Vaccine Adjuvants Sales by Type (2020-2025)
6.3 APAC Vaccine Adjuvants Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine Adjuvants by Country
7.1.1 Europe Vaccine Adjuvants Sales by Country (2020-2025)
7.1.2 Europe Vaccine Adjuvants Revenue by Country (2020-2025)
7.2 Europe Vaccine Adjuvants Sales by Type (2020-2025)
7.3 Europe Vaccine Adjuvants Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine Adjuvants by Country
8.1.1 Middle East & Africa Vaccine Adjuvants Sales by Country (2020-2025)
8.1.2 Middle East & Africa Vaccine Adjuvants Revenue by Country (2020-2025)
8.2 Middle East & Africa Vaccine Adjuvants Sales by Type (2020-2025)
8.3 Middle East & Africa Vaccine Adjuvants Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine Adjuvants
10.3 Manufacturing Process Analysis of Vaccine Adjuvants
10.4 Industry Chain Structure of Vaccine Adjuvants
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine Adjuvants Distributors
11.3 Vaccine Adjuvants Customer
12 WORLD FORECAST REVIEW FOR VACCINE ADJUVANTS BY GEOGRAPHIC REGION
12.1 Global Vaccine Adjuvants Market Size Forecast by Region
12.1.1 Global Vaccine Adjuvants Forecast by Region (2026-2031)
12.1.2 Global Vaccine Adjuvants Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Vaccine Adjuvants Forecast by Type (2026-2031)
12.7 Global Vaccine Adjuvants Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Vaccine Adjuvants Product Portfolios and Specifications
13.1.3 GSK Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 CSL Limited
13.2.1 CSL Limited Company Information
13.2.2 CSL Limited Vaccine Adjuvants Product Portfolios and Specifications
13.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Limited Main Business Overview
13.2.5 CSL Limited Latest Developments
13.3 Croda
13.3.1 Croda Company Information
13.3.2 Croda Vaccine Adjuvants Product Portfolios and Specifications
13.3.3 Croda Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Croda Main Business Overview
13.3.5 Croda Latest Developments
13.4 SEPPIC
13.4.1 SEPPIC Company Information
13.4.2 SEPPIC Vaccine Adjuvants Product Portfolios and Specifications
13.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 SEPPIC Main Business Overview
13.4.5 SEPPIC Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Vaccine Adjuvants Product Portfolios and Specifications
13.5.3 Sanofi Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Zhifei Biological
13.6.1 Zhifei Biological Company Information
13.6.2 Zhifei Biological Vaccine Adjuvants Product Portfolios and Specifications
13.6.3 Zhifei Biological Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Zhifei Biological Main Business Overview
13.6.5 Zhifei Biological Latest Developments
13.7 Escon
13.7.1 Escon Company Information
13.7.2 Escon Vaccine Adjuvants Product Portfolios and Specifications
13.7.3 Escon Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Escon Main Business Overview
13.7.5 Escon Latest Developments
13.8 Huanuotai Biological
13.8.1 Huanuotai Biological Company Information
13.8.2 Huanuotai Biological Vaccine Adjuvants Product Portfolios and Specifications
13.8.3 Huanuotai Biological Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Huanuotai Biological Main Business Overview
13.8.5 Huanuotai Biological Latest Developments
13.9 Rico Bio
13.9.1 Rico Bio Company Information
13.9.2 Rico Bio Vaccine Adjuvants Product Portfolios and Specifications
13.9.3 Rico Bio Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Rico Bio Main Business Overview
13.9.5 Rico Bio Latest Developments
13.10 SDA BIO
13.10.1 SDA BIO Company Information
13.10.2 SDA BIO Vaccine Adjuvants Product Portfolios and Specifications
13.10.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 SDA BIO Main Business Overview
13.10.5 SDA BIO Latest Developments
13.11 SPI Pharma
13.11.1 SPI Pharma Company Information
13.11.2 SPI Pharma Vaccine Adjuvants Product Portfolios and Specifications
13.11.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 SPI Pharma Main Business Overview
13.11.5 SPI Pharma Latest Developments
13.12 Phibro Animal Health
13.12.1 Phibro Animal Health Company Information
13.12.2 Phibro Animal Health Vaccine Adjuvants Product Portfolios and Specifications
13.12.3 Phibro Animal Health Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Phibro Animal Health Main Business Overview
13.12.5 Phibro Animal Health Latest Developments
13.13 Vertellus
13.13.1 Vertellus Company Information
13.13.2 Vertellus Vaccine Adjuvants Product Portfolios and Specifications
13.13.3 Vertellus Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Vertellus Main Business Overview
13.13.5 Vertellus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccine Adjuvants Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vaccine Adjuvants Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Emulsion Adjuvants
Table 4. Major Players of Mineral Adjuvants
Table 5. Major Players of Others
Table 6. Global Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 7. Global Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Table 8. Global Vaccine Adjuvants Revenue by Type (2020-2025) & ($ million)
Table 9. Global Vaccine Adjuvants Revenue Market Share by Type (2020-2025)
Table 10. Global Vaccine Adjuvants Sale Price by Type (2020-2025) & (USD/Kg)
Table 11. Global Vaccine Adjuvants Sale by Application (2020-2025) & (MT)
Table 12. Global Vaccine Adjuvants Sale Market Share by Application (2020-2025)
Table 13. Global Vaccine Adjuvants Revenue by Application (2020-2025) & ($ million)
Table 14. Global Vaccine Adjuvants Revenue Market Share by Application (2020-2025)
Table 15. Global Vaccine Adjuvants Sale Price by Application (2020-2025) & (USD/Kg)
Table 16. Global Vaccine Adjuvants Sales by Company (2020-2025) & (MT)
Table 17. Global Vaccine Adjuvants Sales Market Share by Company (2020-2025)
Table 18. Global Vaccine Adjuvants Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Vaccine Adjuvants Revenue Market Share by Company (2020-2025)
Table 20. Global Vaccine Adjuvants Sale Price by Company (2020-2025) & (USD/Kg)
Table 21. Key Manufacturers Vaccine Adjuvants Producing Area Distribution and Sales Area
Table 22. Players Vaccine Adjuvants Products Offered
Table 23. Vaccine Adjuvants Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Vaccine Adjuvants Sales by Geographic Region (2020-2025) & (MT)
Table 27. Global Vaccine Adjuvants Sales Market Share Geographic Region (2020-2025)
Table 28. Global Vaccine Adjuvants Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Vaccine Adjuvants Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Vaccine Adjuvants Sales by Country/Region (2020-2025) & (MT)
Table 31. Global Vaccine Adjuvants Sales Market Share by Country/Region (2020-2025)
Table 32. Global Vaccine Adjuvants Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Vaccine Adjuvants Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 35. Americas Vaccine Adjuvants Sales Market Share by Country (2020-2025)
Table 36. Americas Vaccine Adjuvants Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 38. Americas Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 39. APAC Vaccine Adjuvants Sales by Region (2020-2025) & (MT)
Table 40. APAC Vaccine Adjuvants Sales Market Share by Region (2020-2025)
Table 41. APAC Vaccine Adjuvants Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 43. APAC Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 44. Europe Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 45. Europe Vaccine Adjuvants Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 47. Europe Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 48. Middle East & Africa Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 49. Middle East & Africa Vaccine Adjuvants Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 51. Middle East & Africa Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 52. Key Market Drivers & Growth Opportunities of Vaccine Adjuvants
Table 53. Key Market Challenges & Risks of Vaccine Adjuvants
Table 54. Key Industry Trends of Vaccine Adjuvants
Table 55. Vaccine Adjuvants Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Vaccine Adjuvants Distributors List
Table 58. Vaccine Adjuvants Customer List
Table 59. Global Vaccine Adjuvants Sales Forecast by Region (2026-2031) & (MT)
Table 60. Global Vaccine Adjuvants Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Vaccine Adjuvants Sales Forecast by Country (2026-2031) & (MT)
Table 62. Americas Vaccine Adjuvants Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Vaccine Adjuvants Sales Forecast by Region (2026-2031) & (MT)
Table 64. APAC Vaccine Adjuvants Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Vaccine Adjuvants Sales Forecast by Country (2026-2031) & (MT)
Table 66. Europe Vaccine Adjuvants Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Vaccine Adjuvants Sales Forecast by Country (2026-2031) & (MT)
Table 68. Middle East & Africa Vaccine Adjuvants Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Vaccine Adjuvants Sales Forecast by Type (2026-2031) & (MT)
Table 70. Global Vaccine Adjuvants Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Vaccine Adjuvants Sales Forecast by Application (2026-2031) & (MT)
Table 72. Global Vaccine Adjuvants Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. GSK Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 74. GSK Vaccine Adjuvants Product Portfolios and Specifications
Table 75. GSK Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 76. GSK Main Business
Table 77. GSK Latest Developments
Table 78. CSL Limited Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 79. CSL Limited Vaccine Adjuvants Product Portfolios and Specifications
Table 80. CSL Limited Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 81. CSL Limited Main Business
Table 82. CSL Limited Latest Developments
Table 83. Croda Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 84. Croda Vaccine Adjuvants Product Portfolios and Specifications
Table 85. Croda Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 86. Croda Main Business
Table 87. Croda Latest Developments
Table 88. SEPPIC Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 89. SEPPIC Vaccine Adjuvants Product Portfolios and Specifications
Table 90. SEPPIC Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 91. SEPPIC Main Business
Table 92. SEPPIC Latest Developments
Table 93. Sanofi Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Vaccine Adjuvants Product Portfolios and Specifications
Table 95. Sanofi Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. Zhifei Biological Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 99. Zhifei Biological Vaccine Adjuvants Product Portfolios and Specifications
Table 100. Zhifei Biological Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 101. Zhifei Biological Main Business
Table 102. Zhifei Biological Latest Developments
Table 103. Escon Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 104. Escon Vaccine Adjuvants Product Portfolios and Specifications
Table 105. Escon Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 106. Escon Main Business
Table 107. Escon Latest Developments
Table 108. Huanuotai Biological Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 109. Huanuotai Biological Vaccine Adjuvants Product Portfolios and Specifications
Table 110. Huanuotai Biological Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 111. Huanuotai Biological Main Business
Table 112. Huanuotai Biological Latest Developments
Table 113. Rico Bio Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 114. Rico Bio Vaccine Adjuvants Product Portfolios and Specifications
Table 115. Rico Bio Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 116. Rico Bio Main Business
Table 117. Rico Bio Latest Developments
Table 118. SDA BIO Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 119. SDA BIO Vaccine Adjuvants Product Portfolios and Specifications
Table 120. SDA BIO Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 121. SDA BIO Main Business
Table 122. SDA BIO Latest Developments
Table 123. SPI Pharma Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 124. SPI Pharma Vaccine Adjuvants Product Portfolios and Specifications
Table 125. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 126. SPI Pharma Main Business
Table 127. SPI Pharma Latest Developments
Table 128. Phibro Animal Health Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 129. Phibro Animal Health Vaccine Adjuvants Product Portfolios and Specifications
Table 130. Phibro Animal Health Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 131. Phibro Animal Health Main Business
Table 132. Phibro Animal Health Latest Developments
Table 133. Vertellus Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 134. Vertellus Vaccine Adjuvants Product Portfolios and Specifications
Table 135. Vertellus Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 136. Vertellus Main Business
Table 137. Vertellus Latest Developments
Table 1. Vaccine Adjuvants Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vaccine Adjuvants Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Emulsion Adjuvants
Table 4. Major Players of Mineral Adjuvants
Table 5. Major Players of Others
Table 6. Global Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 7. Global Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Table 8. Global Vaccine Adjuvants Revenue by Type (2020-2025) & ($ million)
Table 9. Global Vaccine Adjuvants Revenue Market Share by Type (2020-2025)
Table 10. Global Vaccine Adjuvants Sale Price by Type (2020-2025) & (USD/Kg)
Table 11. Global Vaccine Adjuvants Sale by Application (2020-2025) & (MT)
Table 12. Global Vaccine Adjuvants Sale Market Share by Application (2020-2025)
Table 13. Global Vaccine Adjuvants Revenue by Application (2020-2025) & ($ million)
Table 14. Global Vaccine Adjuvants Revenue Market Share by Application (2020-2025)
Table 15. Global Vaccine Adjuvants Sale Price by Application (2020-2025) & (USD/Kg)
Table 16. Global Vaccine Adjuvants Sales by Company (2020-2025) & (MT)
Table 17. Global Vaccine Adjuvants Sales Market Share by Company (2020-2025)
Table 18. Global Vaccine Adjuvants Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Vaccine Adjuvants Revenue Market Share by Company (2020-2025)
Table 20. Global Vaccine Adjuvants Sale Price by Company (2020-2025) & (USD/Kg)
Table 21. Key Manufacturers Vaccine Adjuvants Producing Area Distribution and Sales Area
Table 22. Players Vaccine Adjuvants Products Offered
Table 23. Vaccine Adjuvants Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Vaccine Adjuvants Sales by Geographic Region (2020-2025) & (MT)
Table 27. Global Vaccine Adjuvants Sales Market Share Geographic Region (2020-2025)
Table 28. Global Vaccine Adjuvants Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Vaccine Adjuvants Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Vaccine Adjuvants Sales by Country/Region (2020-2025) & (MT)
Table 31. Global Vaccine Adjuvants Sales Market Share by Country/Region (2020-2025)
Table 32. Global Vaccine Adjuvants Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Vaccine Adjuvants Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 35. Americas Vaccine Adjuvants Sales Market Share by Country (2020-2025)
Table 36. Americas Vaccine Adjuvants Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 38. Americas Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 39. APAC Vaccine Adjuvants Sales by Region (2020-2025) & (MT)
Table 40. APAC Vaccine Adjuvants Sales Market Share by Region (2020-2025)
Table 41. APAC Vaccine Adjuvants Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 43. APAC Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 44. Europe Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 45. Europe Vaccine Adjuvants Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 47. Europe Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 48. Middle East & Africa Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 49. Middle East & Africa Vaccine Adjuvants Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Vaccine Adjuvants Sales by Type (2020-2025) & (MT)
Table 51. Middle East & Africa Vaccine Adjuvants Sales by Application (2020-2025) & (MT)
Table 52. Key Market Drivers & Growth Opportunities of Vaccine Adjuvants
Table 53. Key Market Challenges & Risks of Vaccine Adjuvants
Table 54. Key Industry Trends of Vaccine Adjuvants
Table 55. Vaccine Adjuvants Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Vaccine Adjuvants Distributors List
Table 58. Vaccine Adjuvants Customer List
Table 59. Global Vaccine Adjuvants Sales Forecast by Region (2026-2031) & (MT)
Table 60. Global Vaccine Adjuvants Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Vaccine Adjuvants Sales Forecast by Country (2026-2031) & (MT)
Table 62. Americas Vaccine Adjuvants Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Vaccine Adjuvants Sales Forecast by Region (2026-2031) & (MT)
Table 64. APAC Vaccine Adjuvants Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Vaccine Adjuvants Sales Forecast by Country (2026-2031) & (MT)
Table 66. Europe Vaccine Adjuvants Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Vaccine Adjuvants Sales Forecast by Country (2026-2031) & (MT)
Table 68. Middle East & Africa Vaccine Adjuvants Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Vaccine Adjuvants Sales Forecast by Type (2026-2031) & (MT)
Table 70. Global Vaccine Adjuvants Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Vaccine Adjuvants Sales Forecast by Application (2026-2031) & (MT)
Table 72. Global Vaccine Adjuvants Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. GSK Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 74. GSK Vaccine Adjuvants Product Portfolios and Specifications
Table 75. GSK Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 76. GSK Main Business
Table 77. GSK Latest Developments
Table 78. CSL Limited Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 79. CSL Limited Vaccine Adjuvants Product Portfolios and Specifications
Table 80. CSL Limited Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 81. CSL Limited Main Business
Table 82. CSL Limited Latest Developments
Table 83. Croda Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 84. Croda Vaccine Adjuvants Product Portfolios and Specifications
Table 85. Croda Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 86. Croda Main Business
Table 87. Croda Latest Developments
Table 88. SEPPIC Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 89. SEPPIC Vaccine Adjuvants Product Portfolios and Specifications
Table 90. SEPPIC Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 91. SEPPIC Main Business
Table 92. SEPPIC Latest Developments
Table 93. Sanofi Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Vaccine Adjuvants Product Portfolios and Specifications
Table 95. Sanofi Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. Zhifei Biological Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 99. Zhifei Biological Vaccine Adjuvants Product Portfolios and Specifications
Table 100. Zhifei Biological Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 101. Zhifei Biological Main Business
Table 102. Zhifei Biological Latest Developments
Table 103. Escon Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 104. Escon Vaccine Adjuvants Product Portfolios and Specifications
Table 105. Escon Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 106. Escon Main Business
Table 107. Escon Latest Developments
Table 108. Huanuotai Biological Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 109. Huanuotai Biological Vaccine Adjuvants Product Portfolios and Specifications
Table 110. Huanuotai Biological Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 111. Huanuotai Biological Main Business
Table 112. Huanuotai Biological Latest Developments
Table 113. Rico Bio Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 114. Rico Bio Vaccine Adjuvants Product Portfolios and Specifications
Table 115. Rico Bio Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 116. Rico Bio Main Business
Table 117. Rico Bio Latest Developments
Table 118. SDA BIO Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 119. SDA BIO Vaccine Adjuvants Product Portfolios and Specifications
Table 120. SDA BIO Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 121. SDA BIO Main Business
Table 122. SDA BIO Latest Developments
Table 123. SPI Pharma Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 124. SPI Pharma Vaccine Adjuvants Product Portfolios and Specifications
Table 125. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 126. SPI Pharma Main Business
Table 127. SPI Pharma Latest Developments
Table 128. Phibro Animal Health Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 129. Phibro Animal Health Vaccine Adjuvants Product Portfolios and Specifications
Table 130. Phibro Animal Health Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 131. Phibro Animal Health Main Business
Table 132. Phibro Animal Health Latest Developments
Table 133. Vertellus Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 134. Vertellus Vaccine Adjuvants Product Portfolios and Specifications
Table 135. Vertellus Vaccine Adjuvants Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 136. Vertellus Main Business
Table 137. Vertellus Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vaccine Adjuvants
Figure 2. Vaccine Adjuvants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine Adjuvants Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Vaccine Adjuvants Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vaccine Adjuvants Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vaccine Adjuvants Sales Market Share by Country/Region (2024)
Figure 10. Vaccine Adjuvants Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Emulsion Adjuvants
Figure 12. Product Picture of Mineral Adjuvants
Figure 13. Product Picture of Others
Figure 14. Global Vaccine Adjuvants Sales Market Share by Type in 2025
Figure 15. Global Vaccine Adjuvants Revenue Market Share by Type (2020-2025)
Figure 16. Vaccine Adjuvants Consumed in Human Vaccine
Figure 17. Global Vaccine Adjuvants Market: Human Vaccine (2020-2025) & (MT)
Figure 18. Vaccine Adjuvants Consumed in Veterinary Vaccine
Figure 19. Global Vaccine Adjuvants Market: Veterinary Vaccine (2020-2025) & (MT)
Figure 20. Global Vaccine Adjuvants Sale Market Share by Application (2024)
Figure 21. Global Vaccine Adjuvants Revenue Market Share by Application in 2025
Figure 22. Vaccine Adjuvants Sales by Company in 2025 (MT)
Figure 23. Global Vaccine Adjuvants Sales Market Share by Company in 2025
Figure 24. Vaccine Adjuvants Revenue by Company in 2025 ($ millions)
Figure 25. Global Vaccine Adjuvants Revenue Market Share by Company in 2025
Figure 26. Global Vaccine Adjuvants Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Vaccine Adjuvants Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Vaccine Adjuvants Sales 2020-2025 (MT)
Figure 29. Americas Vaccine Adjuvants Revenue 2020-2025 ($ millions)
Figure 30. APAC Vaccine Adjuvants Sales 2020-2025 (MT)
Figure 31. APAC Vaccine Adjuvants Revenue 2020-2025 ($ millions)
Figure 32. Europe Vaccine Adjuvants Sales 2020-2025 (MT)
Figure 33. Europe Vaccine Adjuvants Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Vaccine Adjuvants Sales 2020-2025 (MT)
Figure 35. Middle East & Africa Vaccine Adjuvants Revenue 2020-2025 ($ millions)
Figure 36. Americas Vaccine Adjuvants Sales Market Share by Country in 2025
Figure 37. Americas Vaccine Adjuvants Revenue Market Share by Country (2020-2025)
Figure 38. Americas Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 39. Americas Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 40. United States Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Vaccine Adjuvants Sales Market Share by Region in 2025
Figure 45. APAC Vaccine Adjuvants Revenue Market Share by Region (2020-2025)
Figure 46. APAC Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 47. APAC Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 48. China Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 52. India Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 54. China Taiwan Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Vaccine Adjuvants Sales Market Share by Country in 2025
Figure 56. Europe Vaccine Adjuvants Revenue Market Share by Country (2020-2025)
Figure 57. Europe Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 58. Europe Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 59. Germany Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 60. France Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Vaccine Adjuvants Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 66. Middle East & Africa Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 67. Egypt Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 70. Turkey Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Vaccine Adjuvants in 2025
Figure 73. Manufacturing Process Analysis of Vaccine Adjuvants
Figure 74. Industry Chain Structure of Vaccine Adjuvants
Figure 75. Channels of Distribution
Figure 76. Global Vaccine Adjuvants Sales Market Forecast by Region (2026-2031)
Figure 77. Global Vaccine Adjuvants Revenue Market Share Forecast by Region (2026-2031)
Figure 78. Global Vaccine Adjuvants Sales Market Share Forecast by Type (2026-2031)
Figure 79. Global Vaccine Adjuvants Revenue Market Share Forecast by Type (2026-2031)
Figure 80. Global Vaccine Adjuvants Sales Market Share Forecast by Application (2026-2031)
Figure 81. Global Vaccine Adjuvants Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Vaccine Adjuvants
Figure 2. Vaccine Adjuvants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine Adjuvants Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Vaccine Adjuvants Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vaccine Adjuvants Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vaccine Adjuvants Sales Market Share by Country/Region (2024)
Figure 10. Vaccine Adjuvants Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Emulsion Adjuvants
Figure 12. Product Picture of Mineral Adjuvants
Figure 13. Product Picture of Others
Figure 14. Global Vaccine Adjuvants Sales Market Share by Type in 2025
Figure 15. Global Vaccine Adjuvants Revenue Market Share by Type (2020-2025)
Figure 16. Vaccine Adjuvants Consumed in Human Vaccine
Figure 17. Global Vaccine Adjuvants Market: Human Vaccine (2020-2025) & (MT)
Figure 18. Vaccine Adjuvants Consumed in Veterinary Vaccine
Figure 19. Global Vaccine Adjuvants Market: Veterinary Vaccine (2020-2025) & (MT)
Figure 20. Global Vaccine Adjuvants Sale Market Share by Application (2024)
Figure 21. Global Vaccine Adjuvants Revenue Market Share by Application in 2025
Figure 22. Vaccine Adjuvants Sales by Company in 2025 (MT)
Figure 23. Global Vaccine Adjuvants Sales Market Share by Company in 2025
Figure 24. Vaccine Adjuvants Revenue by Company in 2025 ($ millions)
Figure 25. Global Vaccine Adjuvants Revenue Market Share by Company in 2025
Figure 26. Global Vaccine Adjuvants Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Vaccine Adjuvants Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Vaccine Adjuvants Sales 2020-2025 (MT)
Figure 29. Americas Vaccine Adjuvants Revenue 2020-2025 ($ millions)
Figure 30. APAC Vaccine Adjuvants Sales 2020-2025 (MT)
Figure 31. APAC Vaccine Adjuvants Revenue 2020-2025 ($ millions)
Figure 32. Europe Vaccine Adjuvants Sales 2020-2025 (MT)
Figure 33. Europe Vaccine Adjuvants Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Vaccine Adjuvants Sales 2020-2025 (MT)
Figure 35. Middle East & Africa Vaccine Adjuvants Revenue 2020-2025 ($ millions)
Figure 36. Americas Vaccine Adjuvants Sales Market Share by Country in 2025
Figure 37. Americas Vaccine Adjuvants Revenue Market Share by Country (2020-2025)
Figure 38. Americas Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 39. Americas Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 40. United States Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Vaccine Adjuvants Sales Market Share by Region in 2025
Figure 45. APAC Vaccine Adjuvants Revenue Market Share by Region (2020-2025)
Figure 46. APAC Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 47. APAC Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 48. China Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 52. India Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 54. China Taiwan Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Vaccine Adjuvants Sales Market Share by Country in 2025
Figure 56. Europe Vaccine Adjuvants Revenue Market Share by Country (2020-2025)
Figure 57. Europe Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 58. Europe Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 59. Germany Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 60. France Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Vaccine Adjuvants Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 66. Middle East & Africa Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 67. Egypt Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 70. Turkey Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Vaccine Adjuvants Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Vaccine Adjuvants in 2025
Figure 73. Manufacturing Process Analysis of Vaccine Adjuvants
Figure 74. Industry Chain Structure of Vaccine Adjuvants
Figure 75. Channels of Distribution
Figure 76. Global Vaccine Adjuvants Sales Market Forecast by Region (2026-2031)
Figure 77. Global Vaccine Adjuvants Revenue Market Share Forecast by Region (2026-2031)
Figure 78. Global Vaccine Adjuvants Sales Market Share Forecast by Type (2026-2031)
Figure 79. Global Vaccine Adjuvants Revenue Market Share Forecast by Type (2026-2031)
Figure 80. Global Vaccine Adjuvants Sales Market Share Forecast by Application (2026-2031)
Figure 81. Global Vaccine Adjuvants Revenue Market Share Forecast by Application (2026-2031)
